Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

15.4%

2 terminated out of 13 trials

Success Rate

75.0%

-11.5% vs benchmark

Late-Stage Pipeline

31%

4 trials in Phase 3/4

Results Transparency

50%

3 of 6 completed with results

Key Signals

3 with results75% success

Data Visualizations

Phase Distribution

12Total
Not Applicable (7)
P 2 (1)
P 3 (1)
P 4 (3)

Trial Status

Completed6
Terminated2
Recruiting2
Suspended1
Unknown1
Not Yet Recruiting1

Trial Success Rate

75.0%

Benchmark: 86.5%

Based on 6 completed trials

Clinical Trials (13)

Research Network

Activity Timeline